Gain Therapeutics
GANX
GANX
28 hedge funds and large institutions have $3.89M invested in Gain Therapeutics in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 6 closing their positions.
Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
10
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $3.39K | 2,650 | -1,106 | -29% |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $2.21K | 1,729 | -2,903 | -63% |
|
|
RJA
28
Raymond James & Associates
St Petersburg,
Florida
| – | – | -260,019 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 159 | -248,341 | -100% |
|
30
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | -43,062 | Closed |
|
31
Citadel Advisors
Miami,
Florida
| – | – | -4,223 | Closed |
|
|
HPC
32
HM Payson & Co
Portland,
Maine
| – | – | -1,000 | Closed |
|
33
Citigroup
New York
| – | – | -684 | Closed |
|
|
NA
34
NewEdge Advisors
New Orleans,
Louisiana
| – | – | -225 | Closed |
|
|
CFGS
35
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|